A carregar...
Elevated serum levels of soluble CD14 in HBeAg‐positive chronic HBV patients upon Peginterferon treatment are associated with treatment response
Pegylated IFNα (PEG‐IFN) is one of the treatment options for chronic HBV (CHB) patients. However, the high patient treatment burden and limited response rate together clearly ask for biomarkers to predict PEG‐IFN response. Soluble CD14 (sCD14) is considered a marker for immune activation and has bee...
Na minha lista:
| Publicado no: | J Viral Hepat |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6852593/ https://ncbi.nlm.nih.gov/pubmed/31090247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13127 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|